Concepedia

Stephen Antonysamy

SA

17

Publications

1.6K

Citations

15

H-Index

2005

Active since

Affiliations

Eli Lilly (United States)(Current)

Princess Margaret Cancer Centre

University of Toronto

Structural Genomics Consortium

Argonne National Laboratory

Stephen Antonysamy is an author at Eli Lilly (United States) specializing in medicine, natural sciences, and drug discovery.

Top concepts

Publications per year

2005–2024

17

Publications

17

Crystal structure of the human PRMT5:MEP50 complex

Stephen Antonysamy, Zahid Bonday, Robert M. Campbell et al. · Proceedings of the National Academy of Sciences · 2012 · 358 citations · Full text

, , +15

Structural analysis of a set of proteins resulting from a bacterial genomics project

John Badger, J.M. Sauder, J.M. Adams et al. · Proteins Structure Function and Bioinformatics · 2005 · 245 citations

Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the <i>RB1</i> Tumor Suppressor Gene

Xueqian Gong, Jian Du, Stephen H. Parsons et al. · Cancer Discovery · 2018 · 220 citations

LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity

Zahid Bonday, Guillermo S. Cortez, Michael J. Grogan et al. · ACS Medicinal Chemistry Letters · 2018 · 179 citations · Full text

LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2

Hannah Nguyen, Abdellah Allali‐Hassani, Stephen Antonysamy et al. · Journal of Biological Chemistry · 2015 · 125 citations · Full text

Rows per page

1–5 of 17